Zimmer Biomet Holdings logo

Zimmer Biomet Holdings (ZBH) Q3 2024 Earnings

ZBH·Reported October 30, 2024·Before market open

Zimmer Biomet Holdings reported Q3 2024 revenue of $1.8B, beat analyst consensus of $1.8B by $26.0M. Diluted EPS came in at $1.74.

Revenue
$1.8Bbeat by $26.0M
Consensus: $1.8B
Diluted EPS
$1.74met estimate
Consensus: $1.74
SEC

SEC Filings

Earnings release8-K not filed yet

Financial Snapshot

Trailing eight quarters through Q3 2024

Net Income

View metric

Operating Cash Flow

View metric

EPS (Diluted)

View metric

Q3 2024 Earnings FAQ

Common questions about Zimmer Biomet Holdings's Q3 2024 earnings report.

Zimmer Biomet Holdings (ZBH) reported Q3 2024 earnings on October 30, 2024 before market open.

Zimmer Biomet Holdings reported revenue of $1.8B and diluted EPS of $1.74 for Q3 2024.

Revenue beat the consensus estimate of $1.8B by $26.0M. EPS beat the consensus estimate of $1.74 by $0.00.

You can read the 10-Q periodic report (0000950170-24-118959) directly on SEC EDGAR. The filing index links above go to sec.gov.